
Non-US-born adults had higher CRC screening nonadherence than US-born adults, particularly those with less than 15 years of US residence.
In this video, Mark Zitter, MBA, CEO of the Zitter Group, speaks about how oncology pathways are affecting drug use.
In this video, Mark Zitter, MBA, CEO of the Zitter Group, speaks about how oncology pathways are affecting drug use.
This video was taken on Thursday, April 19, 2012, at the 24th Annual Academy of Managed Care Pharmacy Conference in San Francisco, CA.






